BioInvent International AB
OTC:BOVNF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of BioInvent International AB (BOVNF) under the Base Case is USD per share. Compared with the current market price of 0.2798 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What BioInvent International AB Does
BioInvent International AB is a Swedish biotech company that discovers and develops antibody-based medicines, mainly for cancer. It does not sell consumer products; instead, it creates drug candidates and research tools that are meant to be tested in clinical studies and then licensed or partnered with larger drugmakers. Its work centers on finding antibodies that can help the immune system attack tumors or block signals that cancer cells use to grow.
- Headquarters
- Sweden SE
- Employees
- 112
- IPO date
- Jun 12, 2001
Balance Sheet
Continue BOVNF Research
Decided on BioInvent International? Get an email when BOVNF reaches the price you’d buy at. Free with an account.
Other BioInvent International listings
What is the Intrinsic Value of one BOVNF stock?
The intrinsic value for BioInvent International AB (BOVNF) under the Base Case is USD.
Is BOVNF stock undervalued or overvalued?
Compared with the current market price of 0.2798 USD, the stock appears .